iLabKart Technologies will be its authorised partner for the states of Maharashtra and Gujarat
Azooka Labs, a startup incubated by the Society for Innovation and Development at the Indian Institute of Science (IISc), launched mWRAPR, indegenous biological transport and storage medium for research use, focused on genomic sequencing labs, biobanks, and research labs handling biological samples for molecular analysis.
Azooka’s mWRAPR helps in preserving genetic content in all types of biological samples including, microbiomes, saliva, cells, tissues, blood, body fluids, and fecal tubes.
About the launch Prof, B Gurumurthy, CEO, SID said, “With a Global Supply chain crunch limiting accessibility to materials for molecular diagnostics, especially in the area if research, There is now an increasing need for India to be able to domestically manufacture them. While most high quality storage/transport media for biological samples in India are manufactured abroad, we are proud to say that home-grown Azooka Labs is stepping in to fill in that gap, and meet the demand.”
Alex Paul, Co-founder and CEO, Azooka Labs.“India needs to move to molecular tests (PCR/RT PCR Test) but the sample collection kits out currently are not molecular grade. They generally tend to be cheap nutrient based media with significant potential for contamination. RNA WRAPR is the kind of Molecular grade sample collection medium that India needs right now.”
With market deployment of the COVID-19 Diagnostic Series and Research Use Only product series, iLabKart Technologieswill be its authorised partner for the states of Maharashtra and Gujarat. Azooka is expanding its partner network across the APAC regions and rolling out easy payment options via Credit Card or UPI. As an Azooka Distributor for the past year, iLabKart Technologies will be clocking one million units of Azooka products by Q1, 2022.
As the sales partner of Azooka, iLabkart has sold more than 7 lakh units of RNA WRAPR to RV Metropolis Labs. Azooka has been the only COVID collection medium provider that has recorded zero contamination cases.
Prakash Dhirwani, CEO, iLabkart Technologies said, “We are proud to be associated with Azooka and we look forward to reaching out to each and every lab, hospital and institute with this world-class product.”
After the first wave of the COVID-19 pandemic, Azooka’s RNA WRAPR received an incubation-to-market bridge funding from Honeywell and Citigroup to develop a contamination free COVID-19 Viral Transport Medium that can be stored at Room Temperature for upto a week..